Trulieve Cannabis Q4 Adjusted EPS $(0.12) Beats $(0.16) Estimate, Sales $287.00M Beat $267.95M Estimate

Trulieve Cannabis (OTC:TCNNF) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.16) by 25 percent. This is a 33.33 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $287.00 million which beat the analyst consensus estimate of $267.95 million by 7.11 percent. This is a 3.85 percent decrease over sales of $298.50 million the same period last year.